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Abstract: An active site aspartate residue, Asp97, in the methionine 
aminopeptidase (MetAPs) from Escherichia coli (EcMetAP-I) was mutated to 
alanine, glutamate, and asparagine. Asp97 is the lone carboxylate residue 
bound to the crystallographically determined second metal-binding site in 
EcMetAP-I. These mutant EcMetAP-I enzymes have been kinetically and 
spectroscopically characterized. Inductively coupled plasma–atomic emission 
spectroscopy analysis revealed that 1.0 ± 0.1 equivalents of cobalt were 
associated with each of the Asp97-mutated EcMetAP-Is. The effect on activity 
after altering Asp97 to alanine, glutamate or asparagine is, in general, due to 
a ~ 9000-fold decrease in kca towards Met-Gly-Met-Met as compared to the 
wild-type enzyme. The Co(II) d–d spectra for wild-type, D97E and D97A 
EcMetAP-I exhibited very little difference in form, in each case, between the 
monocobalt(II) and dicobalt(II) EcMetAP-I, and only a doubling of intensity 
was observed upon addition of a second Co(II) ion. In contrast, the electronic 
absorption spectra of [Co_(D97N EcMetAP-I)] and [CoCo(D97N EcMetAP-I)] 
were distinct, as were the EPR spectra. On the basis of the observed molar 
absorptivities, the Co(II) ions binding to the D97E, D97A and D97N EcMetAP-I 
active sites are pentacoordinate. Combination of these data suggests that 
mutating the only nonbridging ligand in the second divalent metal-binding site 
in MetAPs to an alanine, which effectively removes the ability of the enzyme 
to form a dinuclear site, provides a MetAP enzyme that retains catalytic 
activity, albeit at extremely low levels. Although mononuclear MetAPs are 
active, the physiologically relevant form of the enzyme is probably dinuclear, 
given that the majority of the data reported to date are consistent with weak 
cooperative binding. 
Keywords: EPR, kinetics, mechanism, methionine aminopeptidases, mutants 
Methionine aminopeptidases (MetAPs) represent a unique class 
of protease that is responsible for the hydrolytic removal of N-terminal 
methionines from proteins and polypeptides [1–4]. In the cytosol of 
eukaryotes, all proteins are initiated with an N-terminal methionine; 
however, all proteins synthesized in prokaryotes, mitochondria and 
chloroplasts are initiated with an N-terminal formylmethionyl that is 
subsequently removed by a deformylase, leaving a free methionine at 
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the N-terminus [2]. The cleavage of this N-terminal methionine by 
MetAPs plays a central role in protein synthesis and maturation [5,6]. 
The physiological importance of MetAP activity is underscored by the 
cellular lethality upon deletion of the MetAP genes in Escherichia coli, 
Salmonella typhimurium, and Saccharomyces cerevisiae [7–10]. 
Moreover, a MetAP from eukaryotes has been identified as the 
molecular target for the antiangiogenesis drugs ovalicin and fumagillin 
[11–15]. Therefore, the inhibition of MetAP activity in malignant 
tumors is critical in preventing tumor vascularization, which leads to 
the growth and proliferation of carcinoma cells. In comparison to 
conventional chemotherapy, antiangiogenic therapy has a number of 
advantages, including low cellular toxicity and a lack of drug resistance 
[14]. 
MetAPs are organized into two classes (type I and type II) on 
the basis of the absence or presence of an extra 62 amino acid 
sequence (of unknown function) inserted near the catalytic domain of 
type II enzymes. The type I MetAPs from E. coli (EcMetAP-I), 
Staphylococcus aureus, Thermotoga maritima and Homo sapiens and 
the type II MetAPs from Homo sapiens and Pyrococcus furiosus 
(PfMetAP-II) have been crystallographically characterized [14,16–21]. 
All six display a novel ‘pita-bread’ fold with an internal pseudo-two-fold 
symmetry that structurally relates the first and second halves of the 
polypeptide chain to each other. Each half contains an antiparallel β-
pleated sheet flanked by two helical segments and a C-terminal loop. 
Both domains contribute conserved residues as ligands to the divalent 
metal ions residing in the active site. Nearly all of the available X-ray 
crystallographic data reported to date reveal a bis(µ-carboxylato) (µ-
aquo/hydroxo) dinuclear core with an additional carboxylate residue at 
each metal site and a single histidine bound to M1 (Fig. 1) [22,23]. 
However, extended X-ray absorption fine structure spectroscopy 
(EXAFS) studies on Co(II)- and Fe(II)-loaded EcMetAP-I did not reveal 
any evidence for a dinuclear site [23]. An X-ray crystal structure of 
EcMetAP-I was recently reported with partial occupancy (40%) of a 
single Mn(II) ion bound in the active site [24]. This structure was 
obtained by adding the transition state analog inhibitor l-norleucine 
phosphonate, in order to impede divalent metal binding to the second 
site, and by limiting the amount of metal ion present during crystal 
growth. This structure provides the first structural verification that 
MetAPs can form mononuclear active sites and that the single divalent 
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metal ion resides on the His171 side of the active site, as previously 
predicted by 1H-NMR spectroscopy and EXAFS [22,23]. 
 
Fig. 1: Active site of EcMetAP-I showing the metal-binding residues, including Asp97. 
Prepared from Protein Data Bank file 2MAT. 
A major controversy currently surrounding MetAPs is whether a 
mononuclear site, a dinuclear site or both can catalyze the cleavage of 
N-terminal methionines in vivo [22,25,26]. A growing number of 
kinetic studies indicate that both type I and type II MetAPs are fully 
active in the presence of only one equivalent (eq.) of divalent metal 
ion [Mn(II), Fe(II), or Co(II)] [22,25,27]. However, kinetic, magnetic 
CD (MCD) and atomic absorption spectrometry data indicated that 
Co(II) ions bind to EcMetAP-I in a weakly cooperative fashion (Hill 
coefficients of 1.3 or 2.1) [26,28]. These data represent the first 
evidence that a dinuclear site can form in EcMetAP-I under 
physiological conditions. Moreover, EPR data recorded on Mn(II)-
loaded EcMetAP-I and PfMetAP-II suggest a small amount of dinuclear 
site formation after the addition of only a quarter equivalent of Mn(II) 
[22,29,30]. In order to determine whether a dinuclear site is required 
for enzymatic activity in MetAPs, the conserved aspartate, which is the 
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lone nonbridging ligand for the M2 site in MetAPs (Fig. 2), was 
mutated in EcMetAP-I to alanine, glutamate, and asparagine. 
 
Fig. 2: Amino acid sequence alignment for selected MetAPs, prolidase and 
aminopeptidase P (AMPP). Prepared from Protein Data Bank files 1C21, 1QXZ, 1O0X, 
1XGO, 1BN5, 1PV9, and 1A16. 
Results 
Metal content of mutant EcMetAP-I enzymes 
The number of tightly bound divalent metal ions was determined 
for each of the mutant EcMetAP-I enzymes by inductively coupled 
plasma–atomic emission spectroscopy (ICP-AES) analysis. Apoenzyme 
samples (30 µm), to which 2–30 eq. of Co(II) were added under 
anaerobic conditions, were dialyzed for 3 h at 4 °C with Chelex-100-
treated, metal-free Hepes buffer (25 mm Hepes, 150 mm KCl, pH 
7.5). ICP-AES analysis revealed that 1.0 ± 0.1 eq. of cobalt was 
associated with each of the Asp97-mutated EcMetAP-I enzymes. As a 
control, metal analyses were also performed on the corresponding 
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Asp82 mutant PfMetAP-II enzymes. ICP-AES analysis of D82A, D82N 
and D82E PfMetAP-II also revealed that 1.0 ± 0.1 eq. of cobalt was 
associated with the enzymes. 
Kinetic analysis of the mutant EcMetAP-I enzymes 
The specific activities of D97A, D97N and D97E EcMetAP-I were 
examined using Met-Gly-Met-Met (MGMM) as the substrate. Apo-forms 
of the variants were all catalytically inactive. Kinetic parameters were 
determined for the Co(II)-reconstituted wild-type and mutated 
enzymes (Table 1). In order to obtain detectable activity levels, 
reactions of D97A, D97N and D97E EcMetAP-I with MGMM were 
allowed to run for > 24 h before quenching of the reactions, as 
compared to 1 min for wild-type EcMetAP-I. The extent of the reaction 
for the variants was obtained from the time dependence of the activity 
of the enzymes. A linear correlation was observed between activity 
and time until 30 h, after which the activity values reached a plateau. 
As a control, substrate was incubated with apo-EcMetAP-I and in 
buffer, neither of which resulted in any observed substrate cleavage. 
All three variants exhibited maximum catalytic activity after the 
addition of only one equivalent of Co(II), which is identical to what was 
found with wild-type EcMetAP-I [22,31]. 
Table 1: Kinetic parameters for Co(II)-loaded wild-type (WT) and D97 
mutated EcMetAP-I towards MGMM at 30 °C and pH 7.5. SA, specific activity. 
 EcMetAP-I 
 
 
 WT D97A D97N D97E 
Km (mm) 3.0 ± 0.1 1.1 ± 0.1 0.6 ± 0.1 1.8 ± 0.1 
kcat (s−1) 18.3 ± 0.5 0.003 ± 0.001 0.001 ± 0.0005 0.002 ± 0.001 
kcat / Km (m−1·s−1) 6.0 × 103 3.0 2.0 1.0 
SA (units·mg−1) 36.1 ± 2 0.006 ± 0.001 0.002 ± 0.001 0.004 ± 0.001 
The effect on activity after altering Asp97 to alanine, glutamate 
or asparagine is, in general, due to a decrease in kcat. The kcat values 
for D97A, D97E and D97N EcMetAP-I are 0.003 ± 0.001, 0.002 ± 
0.001, and 0.001 ± 0.0005 s−1, respectively (Table 1). Thus, the kcat 
value for the variants towards MGMM decreased ~ 9000-fold as 
compared to the wild-type enzyme. For comparison purposes, kcat 
values of D82E, D82N and D82A PfMetAP-II were determined, and 
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were found to be 10 ± 1, 1.4 ± 0.1, and 0.01 ± 0.005 s−1, 
respectively. Thus, the kcat value for D82A PfMetAP-II towards MGMM 
decreased ~ 19 000-fold as compared to wild-type PfMetAP-II, 
whereas D82E PfMetAP-II was only 19-fold less active. As a control, 
we also altered the PfMetAP-II active site histidine (His153), which is 
analogous to His171 in EcMetAP-I, to an alanine. This mutation, not 
surprisingly, resulted in the complete loss of enzymatic activity. 
Moreover, this enzyme does not bind divalent metal ions, as 
determined by ICP-AES analysis. These data clearly establish His153 
(His171) as an essential active site amino acid involved in metal 
binding. 
The Km values for each of D97A, D97E and D97N EcMetAP-I 
decreased in comparison to that of wild-type EcMetAP-I, with the 
largest drop in Km being observed for D97N EcMetAP-I (0.6 ± 0.1 
mm), which contains the most conservative substitution. The observed 
Km value for D97E EcMetAP-I was 1.8 ± 0.1 mm, whereas D97A 
EcMetAP-I exhibited a Km value of 1.1 ± 0.1 mm. Combination of the 
observed kcat and Km values for each EcMetAP-I variant provided the 
catalytic efficiency (kcat/Km) for the Co(II)-loaded enzymes, which was 
decreased 2000-fold, 6100-fold and 3000-fold for D97A, D97E and 
D97N EcMetAP-I, respectively, towards MGMM. In order to confirm the 
accuracy of the Km values, the dissociation constant (Kd) for MGMM 
binding to Co(II)-loaded D97N EcMetAP-I was determined by 
isothermal calorimetry (ITC) and found to be 0.9 mm, which is similar 
in magnitude to the observed Km value. 
Determination of metal-binding constants 
ITC measurements were carried out at 25 ± 0.2 °C for D97E, 
D97A and D97N EcMetAP-I (Fig. 3). Association constants (Ka) for the 
binding of Co(II) were obtained by fitting these data, after subtraction 
of the background heat of dilution, via an iterative process using the 
origin software package. This software package uses a nonlinear least-
square algorithm that allows the concentrations of the titrant and the 
sample to be fitted to the heat-flow-per-injection to an equilibrium 
binding equation for two sets of noninteracting sites. The Ka value, the 
metal–enzyme stoichiometry (p) and the change in enthalpy (ΔH°) 
were allowed to vary during the fitting process (Table 2, Fig. 3). The 
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best fit obtained for D97A EcMetAP-I provided an overall p-value of 2 
for two noninteracting sites, whereas the best fit obtained for D97N 
EcMetAP-I provided an overall p-value of 3 for three noninteracting 
sites. Similarly, the best fit obtained for D97E EcMetAP-I provided an 
overall p-value of 3 for three interacting sites. For D97A EcMetAP-I, Kd 
values of 1.6 ± 1.2 µm and 2.2 ± 0.4 mm were observed, whereas 
D97N EcMetAP-I gave a Kd value of 0.22 ± 0.3 µm and two Kd values 
of 0.2 ± 0.1 mm. Interestingly, D97E EcMetAP-I exhibited cooperative 
binding, giving Kd values of 90 ± 20, 210 ± 100 and 574 ± 150 µm. 
The heat of reaction, measured during the experiment, was converted 
into other thermodynamic parameters using the Gibbs free energy 
relationship. The thermodynamic parameters obtained from ITC 
titrations of Co(II) with wild-type EcMetAP-I and each mutant enzyme 
reveal changes that affect both of the metal-binding sites (Table 3). 
Although the predominant effect is on the second metal-binding site, 
substitution of Asp97 by glutamate and asparagine makes the process 
of binding of the metal ions, particularly for the second metal ion, 
more spontaneous on the basis of more negative Gibbs free energy 
(ΔG) values in comparison to the wild-type enzyme. Substitution of 
Asp97 by alanine does not affect the ΔG value for the binding of the 
first metal ion; however, the entropic factor (TΔS) for the binding of 
the first metal ion decreases in the relative order D97E > wild type > 
D97N > D97A. In addition, TΔS for binding of the second metal ion 
significantly decreases for D97N EcMetAP-I but remains similar in 
magnitude for D97E EcMetAP-I in comparison to the wild-type enzyme. 
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Fig. 3: ITC titration of 70 µm solution of D97E EcMetAP-I with a 5 mm Co(II) solution 
at 25 °C in 25 mm Hepes (pH 7.5) and 150 mm KCl. 
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EcMetAP-I p Kd1, Kd2 (µm) 
WT 1 1.6 ± 0.5 
 2 14 000 ± 5000 
D97A 1 1.6 ± 1.2 
 1 2237 ± 476 
D97N 1 0.22 ± 0.3 
 2 238 ± 100 
D97E 1 90 ± 20 
 1 210 ± 100 
 1 574 ± 150 
Table 2: Dissociation constants (Kd) and metal–enzyme stoichiometry (n) for Co(II) 
binding to wild-type (WT) and variant EcMetAP-I. For each set of data for both WT and 
variant EcMetAP-I, p is the number of Co(II) ions per protein. Data for p = 1 are for 
one Co(II) ion that bound tightly, and data for p = 2 represent two Co(II) ions binding 
to sites on the protein with lower affinity. WT data have been reported in [49]. 
 
EcMetAP-I p 
ΔH1, ΔH2 
(kcal / mol) 
TΔS1,TΔS2 
(kcal·mol−1) 
ΔG1, ΔG2 
(kcal·mol−1) 
WT 1 1.54 × 101 2.33 × 101 −7.91 
 2 1.06 × 103 1.06 × 103 −2.51 
D97A 1 1.42 × 100 9.35 × 100 −7.90 
 1 1.64 × 101 2.00 × 101 −3.61 
D97N 1 1.40 × 100 1.05 × 101 −9.07 
 2 4.20 × 100 9.14 × 100 −4.94 
D97E 1 6.31 × 10−1 8.12 × 103 −5.49 
 1 5.03 × 100 10.02 × 103 −4.99 
 1 6.20 × 100 10.60 × 103 −4.40 
Table 3: Thermodynamic parameters for Co(II) binding to wild-type (WT) and variant 
EcMetAP-I. 
Electronic absorption spectra of Co(II)-loaded mutated 
EcMetAP-I 
The electronic absorption spectra of wild-type, D97A, D97N and 
D97E EcMetAP-I with the addition of one and two equivalents of Co(II) 
were recorded under strict anaerobic conditions in 25 mm Hepes buffer 
(pH 7.5) and 150 mm KCl (Fig. 4). The addition of one equivalent of 
Co(II) to wild-type, D97A, D97N and D97E EcMetAP-I provided 
electronic absorption spectra with three absorption maxima between 
540 and 700 nm, with molar absorptivities ranging from 20 to 80 
m−1·cm−1. In general, the addition of a second equivalent of Co(II) 
increased the molar absortivities of the absorption bands. However, for 
D97N EcMetAP-I, molar absorptivity increased for maxima at 550 and 
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630 nm but diminished for the maxima at 690 nm (Fig. 4). Addition of 
further equivalents of Co(II) led to precipitation for D97N EcMetAP-I, 
no change in molar absorptivity of the absorption maxima for D97A 
EcMetAP-I, but an increase in molar absorptivity for D97E EcMetAP-I. 
 
Fig. 4: Electronic absorption spectra of 1 mm wild-type (black), D97A (green), D97N 
(blue) and D97E (red) EcMetAP-I with increments of one and two equivalents of Co(II) 
in 25 mm Hepes buffer (pH 7.5) and 150 mm KCl. 
For D97E EcMetAP-I, the dissociation constant for the second 
metal-binding site was determined by subtraction of the UV–visible 
spectrum with one equivalent of Co(II) from the other spectra and 
then plotting a binding curve (Fig. 5). The dissociation constants (Kd) 
for the second divalent metal-binding sites of EcMetAP-I D97E were 
obtained by fitting the observed molar absorptivities to Eqn (1), via an 
iterative process that allows both Kd and p to vary (Fig. 5):  
r=pCS/(Kd+CS) 
(1) 
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where p is the number of sites for which interaction with M(II) is 
governed by the intrinsic dissociation constant Kd, and r is the binding 
function calculated by conversion of the fractional saturation (fa) [32]:  
r=𝑓ap 
(2) 
CS, the free metal concentration, was calculated from  
CS=CTS−rCA 
(3) 
where CTS and CA are the total molar concentrations of metal and 
enzyme, respectively. The best fit obtained for the λmax values at 520, 
627 and 685 nm provided a P-value of 1 and Kd values of 0.3 ± 0.1, 
1.1 ± 0.2 and 0.6 ± 0.6 mm, respectively, for D97E EcMetAP-I (Table 
4). 
 
Fig. 5: Binding function r versus CS, the concentration of free metal ions in solution for 
D97E EcMetAP-I in 25 mm Hepes buffer (pH 7.5) and 150 mm KCl at three different 
wavelengths. The solid lines correspond to fits of each data set to Eqn (3). 
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λmax (nm) Kd (mm) 
520 0.3 ± 0.1 
627 1.1 ± 0.2 
685 0.6 ± 0.6 
 
Table 4: Data obtained for the fits of electronic absorption data to Eqn (1). 
EPR studies of Co(II)-loaded D97A, D97E and D97N 
EcMetAP-I 
The EPR spectrum of wild-type EcMetAP-I (Fig. 6A) has been 
well characterized [22], and the form of the signal is invariant from 
0.5 to 2.0 eq. of Co(II). The signal is due to transitions in the MS = | ± 
1/2〉 Kramers’ doublet of S = 3/2, with Δ > gβBS, and exhibits no 
resolved rhombicity or 59Co hyperfine structure. This type of signal is 
typical for protein-bound five- or six-coordinate Co(II) with one or 
more water ligands. A very similar signal was obtained with the mono-
Co(II) form of D97A EcMetAP-I (Fig. 6K) and with the di-Co(II) forms 
of both D97A (Fig. 6L) and D97N (Fig. 6H,J) EcMetAP-I. 
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Fig. 6 
Co(II)-EPR of EcMetAP-I and variants. Traces A, B and D are the EPR spectra of 
[CoCo(WT-EcMetAP-I)] (A), [Co_(D97E-EcMetAP-I)] (B), and [CoCo(D97E-EcMetAP-I)] 
(D). Trace C is a computer simulation of B assuming two species. The major species 
exhibited resolved hyperfine coupling and was simulated with spin Hamiltonian 
parameters S = 3/ 2, MS = |± 1/ 2〉, gx,y = 2.57, gz = 2.67, D >> g BS (50 cm-1), E / 
D = 0.185, Ay = 9.0 × 10−3 cm−1. The minor species was best simulated (gx,y = 2.18, 
gz = 2.6, E / D = 1/ 3, Ay (unresolved) = 4.5 × 10−3 cm−1) assuming some unresolved 
hyperfine coupling, although no direct evidence for this was obtained. Trace E is of 
spectrum D with arbitrary amounts of spectrum A subtracted. Trace F is the 
experimental EPR spectrum of [CoCo(D97E- EcMetAP-I)] recorded in parallel mode 
(B0║ B1). Traces G and I are spectra of [Co_(D97N- EcMetAP-I)], and traces H and J 
are spectra of [CoCo(D97N- EcMetAP-I)]; the insert of H shows the hyperfine region of 
G expanded. Trace K is the spectrum of [Co_(D97A- EcMetAP-I)], and L is of 
[CoCo(D97A-EcMetAP-I)]. Spectra A, B, D and I–K were recorded using 0.2 mW power 
at 8 K. Spectrum F was recorded using 20 mW at 8 K, and spectra G and H were 
recorded using 2 mW at 6 K. Trace G is shown × 2 compared to H, I is shown × 2 
compared to J, and K is shown × 2 compared to L. Other intensities are arbitrary. 
Spectrum F was recorded at 9.37 GHz whereas all other experimental spectra were at 
9.64 GHz. 
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The EPR signals from D97E EcMetAP-I were, however, 
significantly different from those of wild-type EcMetAP-I. The signal 
observed for [Co_(D97E EcMetAP-I)] (Fig. 6B) was complex, and 
computer simulation (Fig. 6C) suggested a dominant species that 
exhibited marked rhombic distortion of the axial zero-field splitting 
(E/D = 0.185) and a 59Co hyperfine interaction of 9 × 10−3 cm−1. 
These parameters are typical for low-symmetry five-coordinate Co(II) 
with a constrained ligand sphere, and suggest that either Co(II) is 
displaced relative to that in [Co_(wild-type EcMetAP-I)] and binds in a 
very different manner altogether, or that the binding mode of the 
carboxylate differs, perhaps being bidentate in D97E EcMetAP-I and 
replacing a water ligand. Further differences between the binding 
modes of Co(II) were observed in the dicobalt(II) form of D97E 
EcMetAP-I. Whereas there was no evidence for significant exchange 
coupling in spectra obtained for wild-type EcMetAP-I, the spectrum of 
[CoCo(D97E EcMetAP-I)] (Fig. 6D) exhibited a feature at geff ~ 12 that 
was suggestive of an integer spin system with S′ = 3. Subtraction of 
the [Co_(D97E EcMetAP-I)] spectrum and the wild-type spectrum 
yielded a difference spectrum (Fig. 6E) with similarities to integer spin 
signals observed in other dicobalt(II) systems [33], and the parallel 
mode EPR signal, with a resonance at geff ~ 11 (Fig. 6F), confirmed 
that the Co(II) ions in [CoCo(D97E EcMetAP-I)] do indeed form a 
weakly exchange-coupled dinuclear center. 
Close examination of the EPR signal from [Co_(D97N EcMetAP-
I)] recorded at 6 K (Fig. 6G) revealed a 59Co hyperfine pattern 
superimposed on the dominant axial signal, indicating the presence of 
two species of Co(II). The pattern was centered at geff ~ 7.9 and, 
interestingly, no other features that could be readily associated with 
this pattern were evident. It is possible, then, that the hyperfine 
pattern in the spectrum of [Co_(D97N EcMetAP-I)] is part of an MS = | 
± 3/2〉 signal, indicative of tetrahedral character for Co(II) ions, for 
which the g⊥ features are unobservable at 9.6 GHz. This explanation is 
also consistent with the loss of the hyperfine pattern upon an increase 
of the temperature by a mere 2 K; MS = | ±3/2〉 signals are often only 
observed at temperatures around 5 K, because of rapid relaxation at 
higher temperatures [34–36]. Despite the superficial similarity of the 
hyperfine patterns observed in the spectra of [Co_(D97N EcMetAP-I)] 
and [Co_(D97E EcMetAP-I)], the Co(II) species from which these 
originate are probably very different. An additional difference between 
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D97N and D97E EcMetAP-I is the lack of evidence for exchange 
coupling in [CoCo(D97N EcMetAP-I)]; the formation of a spin-coupled 
dinuclear center appears to be unique to D97E EcMetAP-I. 
Discussion 
A major stumbling block in the design of small molecule 
inhibitors of MetAPs centers on how many metal ions are present in 
the active site under physiological conditions. Most of the X-ray 
crystallographic data reported for MetAPs indicate that two metal ions 
form a dinuclear active site [24,37–42]. However, kinetic data suggest 
that only one metal ion is required for full enzymatic activity, and 
EXAFS studies on Co(II)-and Fe(II)-loaded EcMetAP-I did not provide 
any evidence for a dinuclear site [22,23,25,27]. Recently, the X-ray 
crystal structure of a mono-Mn(II) EcMetAP-I enzyme bound by l-
norleucine phosphonate was reported, providing the first 
crystallographic data for a mononuclear MetAP [24]. Taken together, 
these data suggest that MetAPs are mononuclear exopeptidases, 
however, kinetic, MCD and atomic absorption spectrometry data 
indicate that Co(II) ions bind to EcMetAP-I in a weakly cooperative 
fashion [26,28]. In order to reconcile these data and determine 
whether a dinuclear site is required for enzymatic activity, as well as 
shed some light on the catalytic role of Asp97 in EcMetAP-I, we 
prepared the D97A, D97E and D97N mutant enzymes. This aspartate 
is strictly conserved in all MetAPs as well as in other enzymes in the 
‘pita-bread’ superfamily (e.g. aminopeptidase P and prolidase) (Fig. 2) 
[14,16,17,19,21,43–46]. Replacement of this conserved aspartate in 
human prolidase by asparagine causes skin abnormalities, recurrent 
infections, and mental retardation [45]. 
On the basis of ICP-AES analyses, both D97A EcMetAP-I and 
D82A PfMetAP-II bind only one divalent metal ion tightly, which is 
identical to what is seen with the wild-type enzyme [22,25]. Therefore, 
the second metal ion is either not present or is loosely associated. 
Consistent with ICP-AES analyses, the Kd value determined for D97A 
EcMetAP-I using ITC indicates the presence of only one tightly bound 
divalent metal ion, and the Kd1 is not affected as compared to the wild-
type enzyme [22,25]. Therefore, the Kd1 value observed for D97A 
EcMetAP-I appears to correspond to the microscopic binding constant 
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of a single metal ion to the histidine-containing side of the EcMetAP-I 
active site, consistent with the hypothesis that substitution of Asp97, a 
residue that functions as the only nonbridging ligand for the second 
metal-binding site, effectively eliminates the ability of a second 
divalent metal ion to bind in the active site. For wild-type EcMetAP-I, 
two additional weak metal-binding events are also observed. Rather 
than three total observed metal-binding sites, D97A EcMetAP-I binds 
only two Co(II) ions, the second probably being in a remote Co(II)-
binding site identified in the X-ray crystal structure of EcMetAP-I 
[15,19]. This remote metal-binding site, or third metal-binding site, 
was also observed in the structure of the type I methionine 
aminopeptidase from H. sapiens [21]. In both enzymes, this remote 
site is on the outer edge of the enzyme and becomes at least partially 
occupied at Co(II) concentrations near 1 mm. Therefore, the second 
divalent metal-binding event observed via ITC for D97A EcMetAP-I is 
postulated to be due to the binding of a Co(II) ion to the remote 
divalent metal-binding site with a Kd2 of 2.2 mm. 
ICP-AES data obtained with D97N and D97E EcMetAP-I are also 
consistent with ITC data, in that only one tightly bound divalent metal 
ion is present in these enzymes. Interestingly, the ITC data obtained 
for D97E EcMetAP-I can only be fitted on the assumption of positive 
cooperativity, similar to that reported by Larrabee et al. for wild-type 
EcMetAP-I [26]. The enhanced cooperativity observed for D97E versus 
wild-type EcMetAP-I is probably due to the increased carbon chain 
length of glutamate versus aspartate, which may adjust the position of 
the second metal-binding site. Similar to what is seen with wild-type 
EcMetAP-I, two weak binding events are also observed for D97N and 
D97E EcMetAP-I, suggesting that a second metal ion can still bind to 
the dinuclear active site even when the bidentate ligand aspartate is 
replaced by glutamate or asparagine. However, the ability of D97N and 
D97E EcMetAP-I to bind a second divalent metal ion increases ~ 60-
fold as compared to wild-type EcMetAP-I. 
The observed kcat values for D97A EcMetAP-I in the presence of 
three equivalents of Co(II) at pH 7.5 decreased 6100-fold as compared 
to the wild-type enzyme. D97N and D97E EcMetAP-I are also slightly 
active, but neither of these mutant enzymes recover wild-type activity 
levels. These data are consistent with a previous study on D97A 
EcMetAP-I, where it was reported that ~ 4% of the residual activity of 
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wild-type EcMetAP-I was retained [47]. On the basis of these data, this 
strictly conserved aspartate is a catalytically important residue but is 
not absolutely required for enzymatic activity. The fact that catalytic 
activity is observed for both D97A EcMetAP-I and D82A PfMetAP-II, 
enzymes in which the second divalent metal-binding site has probably 
been eliminated, suggests that MetAP enzymes can function as 
mononuclear enzymes. Interestingly, the observed Km value for D97A 
EcMetAP-I, which is a partial indicator of the affinity of an enzyme for 
its substrate, decreased by ~ 2.7-fold, suggesting that D97A EcMetAP-
I binds MGMM more tightly than the wild-type enzyme. The 
combination of these data provides a catalytic efficiency for D97A 
EcMetAP-I that is ~ 4000-fold poorer than that of wild-type EcMetAP-I. 
This result is significant in light of the evidence that metal binding to 
D97A EcMetAP-I is probably not cooperative and dinuclear sites do not 
appear to form. 
Further insight into the structure–function relationships of the 
metal-binding sites of EcMetAP-I comes from electronic absorption and 
EPR spectroscopy. The Co(II) d–d spectra for wild-type, D97E and 
D97A EcMetAP-I exhibited very little difference in form, in each case, 
between the monocobalt(II) and dicobalt(II) forms, and only a 
doubling of intensity was observed upon addition of a second Co(II) 
ion. For wild-type and D97A EcMetAP-I, this was reflected in the EPR 
spectra, which also did not differ significantly between the 
monocobalt(II) and dicobalt(II) forms. In contrast, the electronic 
absorption spectra of [Co_(D97N EcMetAP-I)] and [CoCo(D97N 
EcMetAP-I)] are distinct, as are the EPR spectra. On the basis of the 
observed molar absorptivities, the Co(II) ions binding to the D97E, 
D97A and D97N EcMetAP-I active sites are pentacoordinate [48] and, 
apart from a putative tetrahedral species implied by a minor 
component of the EPR spectrum of [Co_(D97N EcMetAP-I)], the EPR 
spectra are all consistent with this interpretation, with high axial 
symmetry being seen in D97A and D97N EcMetAP-I. The minor 
component in D97N EcMetAP-I that is tentatively assigned as a 
tetrahedral Co(II) may be in equilibrium (in solution) with the 
dominant five-coordinate form, and the EPR signal due to this species 
was not exhibited by the dicobalt(II) form of D97N EcMetAP-I. This, in 
turn, suggests that rearrangement of the active site upon binding a 
second Co(II) ion leads to a preference for the higher coordination 
geometry, perhaps due to stabilization of a hitherto weakly bound 
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water ligand by either bridging the two Co(II) ions or via hydrogen 
bonding. 
EPR spectra obtained for D97E EcMetAP-I are particularly 
interesting, and indicate: (a) a much more distorted five-coordinate 
geometry for the first Co(II) ion with a much more rigid ligand 
complement, which probably lacks a solvent ligand; and (b) the 
formation of a weakly exchange-coupled bona fide dinuclear site upon 
the addition of two Co(II) ions. Taken together, the EPR data obtained 
for D97E EcMetAP-I suggest that the loss of aspartate at position 97 is 
not responsible for the observed change in the Co(II) environment of 
the M1 site, but rather the presence of the glutamate side chain. It is 
tempting to speculate that Glu97 provides one or more ligands to the 
first Co(II)-binding site, and indeed bidentate binding of Glu97 may 
prevent binding of the solvent ligand that appears to be present in 
other mono-cobalt(II) species of EcMetAP-I. 
Combination of these data suggests that mutating the only 
nonbridging ligand in the second divalent metal-binding site in MetAPs 
to an alanine, which effectively removes the ability of the enzyme to 
form a dinuclear site, provides a MetAP enzyme that retains catalytic 
activity, albeit at extremely low levels. Reconciliation of these data 
with kinetic, ITC, crystallographic and EXAFS data suggesting that 
MetAPs are mononuclear with kinetic, MCD and EPR data indicating 
that metal binding is cooperative, at first glance, appears to be tricky 
[22,24,26,29,30]. However, the most logical explanation leads to the 
conclusion that metal binding to MetAPs is cooperative, and that 
discrepancies have arisen due to the concentrations of the enzyme 
samples used in the various experiments. For example, ITC data do 
not reveal cooperative binding for divalent metal ions to EcMetAP-I or 
PfMetAP-II but, instead, indicate that one metal ion binds with much 
higher affinity than subsequent metal ions. It should be noted that ITC 
titrations are typically run with enzyme concentrations of 70 µm, and 
most often reveal two sets of binding sites, similar to that observed for 
D97N EcMetAP-I [22]. Likewise, initial activity assays carried out on 
EcMetAP-I and PfMetAP-II used an enzyme concentration of 20 µm, 
which is two orders of magnitude larger than the Kd value determined 
for the first metal-binding site of 0.2 or 0.4 µm, assuming Hill 
coefficients of 1.3 or 2.1, respectively [26,28]. However, a Kd value of 
between 2.5 and 4.0 µm was reported if it was assumed that only a 
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single Co(II)-binding site exists in the low-concentration regime, which 
is within the error of ITC and kinetic Kd values. Spectroscopic and most 
X-ray crystallographic measurements were carried out at much higher 
enzyme (~ 1 mm) and metal concentrations, where a significant 
concentration of dinuclear sites will undoubtedly be present. Under the 
conditions utilized in ITC experiments, any cooperativity in divalent 
metal binding will not be detectable, but may appear in EPR and 
electronic absorption data. As activity titrations and ITC data are not 
particularly sensitive to the type of binding (i.e. cooperativity versus 
two independent binding sites), the weak cooperativity observed by 
Larrabee et al. [26] will not be observed in these experiments but is 
entirely consistent with the EPR and electronic absorption data and, 
indeed, with recent X-ray crystallographic data. Most X-ray structures 
of MetAPs were determined with a large excess of divalent metal ions, 
so only dinuclear sites were observed. However, crystallographic data 
obtained on EcMetAP-I using metal ion / enzyme ratios of 0.5 : 1 
reveal metal ion occupancies of 71% bound to the M1 site and 28% 
bound to the M2 site, consistent with cooperative binding [24]. 
In conclusion, mutating the only nonbridging ligand in the 
second divalent metal-binding site in MetAPs to an alanine, which 
effectively removes the ability of the enzyme to form a dinuclear site, 
provides MetAPs that retain catalytic activity, albeit at extremely low 
levels. Although mononuclear MetAPs are active, the physiologically 
relevant form of the enzyme is probably dinuclear, given that the 
majority of the data reported to date are consistent with weak 
cooperative binding. Therefore, Asp97 primarily functions as a ligand 
for the second divalent metal-binding site, but also probably assists in 
binding and positioning the substrate through interactions with the N-
terminal amine. The data reported herein highlight the complexity of 
the active site of EcMetAP-I, and provide additional insights into the 
role that active site residues play in the hydrolysis of peptides by 
MetAPs as well as aminopeptidase P and prolidase. 
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Experimental procedures 
Mutagenesis, protein expression and purification 
Altered forms of EcMetAP-I were obtained by PCR mutagenesis 
using the following primers: 5′-GGC GAT ATC GTT AAC ATT XXX GTC 
ACC GTA ATC AAA GAT GG-3′ and 5′-CCA TCT TTG ATT ACG GTG AC 
YYY A ATG TTA ACG ATA TCG CC-3′, with XXX standing for GCT, AAT, 
or GAG, and YYY standing for AGC, TTA, or CTC, of EcMetAP-I D97A, 
D97N and D97E. Site-directed mutants were obtained using the Quick 
Change Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA), 
following Stratagene’s procedure. Reaction products were transformed 
into E. coli XL1-Blue competent cells (recA1 endA1 gyrA96 thi-1 
hsdR17 supE44 relA1 lac [F′ proAB lacIqZΔ M15 Tn10(Tetr)]), grown 
on LB agar plates containing kanamycin at a concentration of 50 
µg·mL−1. A single colony of each mutant was grown in 50 mL of LB 
containing 50 µg·mL−1 kanamycin. Plasmids were isolated using Wizard 
Plus Miniprep DNA purification kits (Promega, Madison, WI, USA) or 
Qiaprep Spin Miniprep kits (Qiagene, Valencia, CA, USA). Each 
mutation was confirmed by DNA sequencing (USU Biotechnology 
Center). Plasmids containing the altered EcMetAP-I genes were 
transformed into E. coli BL21 Star(DE3) [F− ompT hsdSB (rB −mB −) gal 
dcm rne131 (DE3)] (Invitrogen, Carlsbad, CA, USA), and stock 
cultures were prepared. The variants were purified in an identical 
manner to the wild-type enzyme [15,31]. Purified variants exhibited a 
single band on SDS /PAGE at an Mr of 29 630. Protein concentrations 
were estimated from the absorbance at 280 nm using an extinction 
coefficient of 16 445 m−1·cm−1 [12,18]. Apo-EcMetAP-I was washed 
free of methionine using Chelex-100-treated methionine-free buffer 
(25 mm Hepes, pH 7.5, 150 mm KCl) and concentrated by microfil-
tration using a Centricon-10 (Amicon, Beverly, MA, USA) prior to all 
kinetic assays. Individual aliquots of apo-EcMetAP-I were routinely 
stored at −80 °C or in liquid nitrogen until needed. Similarly, we also 
prepared D82E, D82N and D82A PfMetAP-II and purified them to 
homogeneity, according to SDS /PAGE analysis. 
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Metal content measurements 
Mutated EcMetAP-I enzyme samples prepared for metal analysis 
were typically 30 µm. Apo-EcMetAP-I samples were incubated 
anaerobically with MCl2, where M = Co(II), for 30 min prior to 
exhaustive anaerobic exchange into Chelex-100-treated buffer as 
previously reported [31]. Metal analyses were performed using ICP-
AES. 
Enzymatic assay of EcMetAP-I enzymes 
All enzymatic assays were performed under strict anaerobic 
conditions in an inert atmosphere glove box (Coy) with a dry bath 
incubator to maintain the temperature at 30 °C. Catalytic activities 
were determined with an error of ± 5%. Enzyme activities for each 
mutated enzyme were determined in 25 mm Hepes buffer (pH 7.5) 
containing 150 mm KCl with the tetrapeptide substrate MGMM. The 
amount of product formation was determined by HPLC (Shimadzu LC-
10A class-VP5). A typical assay involved the addition of 8 µL of metal-
loaded EcMetAP-I enzyme to a 32 µL substrate–buffer mixture at 
30 °C for 1 min. The reaction was quenched by the addition of 40 µL of 
a 1% trifluoroacetic acid solution. Elution of the product was monitored 
at 215 nm following separation on a C8 HPLC column (Phenomenex, 
Luna; 5 µm, 4.6 × 25 cm), as previously described [22,31]. Enzyme 
activities are expressed as units per milligram, where one unit is 
defined as the amount of enzyme that releases 1 µmol of product in 1 
min at 30 °C. 
ITC 
ITC measurements were carried out on a MicroCal OMEGA 
ultrasensitive titration calorimeter. The titrant (CoCl2) and apo-
EcMetAP-I solutions of the mutated enzymes were prepared in Chelex-
100-treated 25 mm Hepes buffer at pH 7.5, containing 150 mm KCl. 
Stock buffer solutions were thoroughly degassed before each titration. 
The enzyme solution (70 µm) was placed in the calorimeter cell and 
stirred at 200 r.p.m. to ensure rapid mixing. Typically, 3 µL of titrant 
was delivered over 7.6 s with a 5-min interval between injections to 
allow for complete equilibration. Each titration was continued until 
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4.5–6 eq. of Co(II) had been added, to ensure that no additional 
complexes were formed in excess titrant. A background titration, 
consisting of the identical titrant solution but only the buffer solution in 
the sample cell, was subtracted from each experimental titration to 
account for heat of dilution. These data were analyzed with a two- or 
three-site binding model by the Windows-based origin software 
package supplied by MicroCal [49]. 
Spectroscopic measurements 
Electronic absorption spectra were recorded on a Shimadzu UV-
3101PC spectrophotometer. All variant apo-EcMetAP-I samples used in 
spectroscopic measurements were made rigorously anaerobic prior to 
incubation with Co(II) (CoCl2, ≥ 99.999%; Strem Chemicals, 
Newburyport, MA) for ~ 30 min at 25 °C. Co(II)-containing samples 
were handled throughout in an anaerobic glove box (Ar /5% H2, ≤ 1 
p.p.m. O2; Coy Laboratories) until frozen. Electronic absorption spectra 
were normalized for the protein concentration and the absorption due 
to uncomplexed Co(II) (ε512 nm = 6.0 m−1·cm−1) [22]. Low-temperature 
EPR spectroscopy was performed using either a Bruker ESP-300E or a 
Bruker EleXsys spectrometer equipped with an ER 4116 DM dual mode 
X-band cavity and an Oxford Instruments ESR-900 helium flow 
cryostat. Background spectra recorded on a buffer sample were 
aligned with and subtracted from experimental spectra as in earlier 
work [33,50]. EPR spectra were recorded at microwave frequencies of 
approximately 9.65 GHz: precise microwave frequencies were 
recorded for individual spectra to ensure precise g-alignment. All 
spectra were recorded at 100 kHz modulation frequency. Other EPR 
running parameters are specified in the figure legends for individual 
samples. EPR simulations were carried out using matrix diagonalization 
(xsophe, Bruker Biospin), assuming a spin Hamiltonian H = βgHS + 
SDS + SAI, with S = 3/ 2 and D > βgHS (= hν). Enzyme 
concentrations for EPR were 1 mm. Mutated enzyme samples for EPR 
were frozen after incubation with the appropriate amount of Co(II) for 
60 min at 25 °C. 
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Abbreviations 
EcMetAP-I type I methionine aminopeptidase from Escherichia coli 
eq. equivalent 
EXAFS extended X-ray absorption fine structure spectroscopy 
ICP-AES inductively coupled plasma–atomic emission spectroscopy 
ITC isothermal calorimetry 
MCD magnetic CD 
MGMM Met-Gly-Met-Met 
PfMetAP-II type II methionine aminopeptidase from Pyrococcus furiosus 
References 
1. Bradshaw RA. Protein translocation and turnover in eukaryotic cells. TIBS. 
1989;14:276–279. 
2. Meinnel T, Mechulam Y, Blanquet S. Methionine as translation start signal – 
a review of the enzymes of the pathway in Escherichia coli. Biochimie. 
1993;75:1061–1075. 
3. Bradshaw RA, Brickey WW, Walker KW. N-terminal processing: the 
methionine aminopeptidase and Nα-acetyl transferase families. TIBS. 
1998;23:263–267. 
4. Arfin SM, Bradshaw RA. Cotranslational processing and protein turnover in 
eukaryotic cells. Biochemistry. 1988;27:7979–7984. 
5. Lowther WT, Matthews BW. Metalloamino-peptidases: common functional 
themes in disparate structural surroundings. Chem Rev. 
2002;102:4581–4607. 
6. Lowther WT, Matthews BW. Structure and function of the methionine 
aminopeptidases. Biochim Biophys Acta. 2000;1477:157–167. 
7. Chang S-YP, McGary EC, Chang S. Methionine aminopeptidase gene of 
Escherichia coli is essential for cell growth. J Bacteriol. 
1989;171:4071–4072. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
FEBS Journal, Vol. 275, No. 24 (December 2008): pg. 6248-6259. DOI. This article is © Wiley and permission has been 
granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission for this article to be 
further copied/distributed or hosted elsewhere without the express permission from Wiley. 
25 
 
8. Chang Y-H, Teichert U, Smith JA. Molecular cloning, sequencing, deletion, 
and overexpression of a methionine aminopeptidase gene from 
Saccharomyces cerevisiae. J Biol Chem. 1992;267:8007–8011. 
9. Li X, Chang Y-H. Amino terminal protein processing in Saccharomyces 
cerevisiae is an essential function that requires two distinct methionine 
aminopeptidases. Proc Natl Acad Sci USA. 1995;92:12357–12361 
10. Miller CG, Kukral AM, Miller JL, Movva NR. pepM is an essential gene in 
Salmonella typhimurium. J Bacteriol. 1989;171:5215–5217. 
11. Taunton J. How to starve a tumor. Chem Biol. 1997;4:493–496. 
12. Griffith EC, Su Z, Turk BE, Chen S, Chang Y-H, Wu Z, Biemann K, Liu JO. 
Methionine aminopeptidase (type 2) is the common target for 
angiogenesis inhibitors AGM-1470 and ovalicin. Chem Biol. 
1997;4:461–471. 
13. Sin N, Meng L, Wang MQ, Wen JJ, Bornmann WG, Crews CM. The anti-
angiogenic agent fumagillin covalently binds and inhibits the 
methionine aminopeptidase, MetAP-2. Proc Natl Acad Sci USA. 
1997;94:6099–6103. 
14. Liu S, Widom J, Kemp CW, Crews CM, Clardy J. Structure of the human 
methionine aminopeptidase-2 complexed with fumagillin. Science. 
1998;282:1324–1327. 
15. Lowther WT, McMillen DA, Orville AM, Matthews BW. The anti-angiogenic 
agent fumagillin covalently modifies a conserved active site histidine in 
the Escherichia coli methionine aminopeptidase. Proc Natl Acad Sci 
USA. 1998;95:12153–12157. 
16. Douangamath A, Dale GE, D’Arcy A, Almstetter M, Eckl R, Frutos-Hoener 
A, Henkel B, Illgen K, Nerdinger S, Schulz H, et al. Crystal structures 
of Staphylococcus aureus methionine aminopeptidase complexed with 
keto heterocycle and aminoketone inhibitors reveal the formation of a 
tetrahedral intermediate. J Med Chem. 2004;47:1325–1328. 
17. Tahirov TH, Oki H, Tsukihara T, Ogasahara K, Yutani K, Ogata K, Izu Y, 
Tsunasawa S, Kato I. Crystal structure of the methionine 
aminopeptidase from the hyperthermophile, Pyrococcus furiosus. J Mol 
Biol. 1998;284:101–124. 
18. Lowther WT, Orville AM, Madden DT, Lim S, Rich DH, Matthews BW. 
Escherichia coli methionine aminopeptidase: implications of 
crystallographic analyses of the native, mutant and inhibited enzymes 
for the mechanism of catalysis. Biochemistry. 1999;38:7678–7688. 
19. Roderick LS, Matthews BW. Structure of the cobalt-dependent methionine 
aminopeptidase from Escherichia coli: a new type of proteolytic 
enzyme. Biochemistry. 1993;32:3907–3912. 
20. Spraggon G, Schwarzenbacher R, Kreusch A, McMullan D, Brinen LS, 
Canaves JM, Dai X, Deacon AM, Elsliger MA, Eshagi S, et al. Crystal 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
FEBS Journal, Vol. 275, No. 24 (December 2008): pg. 6248-6259. DOI. This article is © Wiley and permission has been 
granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission for this article to be 
further copied/distributed or hosted elsewhere without the express permission from Wiley. 
26 
 
structure of a methionine aminopeptidase (TM1478) from Thermotoga 
maritima at 1.9 Ǻ resolution. Proteins. 2004;56:396–400. 
21. Addlagatta A, Hu X, Liu JO, Matthews BW. Structural basis for the 
functional differences between type I and type II human methionine 
aminopeptidases. Biochemistry. 2005;44:14741–14749. 
22. D’Souza VM, Bennett B, Copik AJ, Holz RC. Characterization of the 
divalent metal binding properties of the methionyl aminopeptidase 
from Escherichia coli. Biochemistry. 2000;39:3817–3826. 
23. Cosper NJ, D’Souza V, Scott R, Holz RC. Structural evidence that the 
methionyl aminopeptidase from Escherichia coli is a mononuclear 
metalloprotease. Biochemistry. 2001;40:13302–13309. 
24. Ye QZ, Xie SX, Ma ZQ, Huang M, Hanzlik RP. Structural basis of catalysis 
by monometalated methionine aminopeptidase. Proc Natl Acad Sci 
USA. 2006;103:9470–9475. 
25. Meng L, Ruebush S, D’Souza VM, Copik AJ, Tsunasawa S, Holz RC. 
Overexpression and divalent metal binding studies for the methionyl 
aminopeptidase from Pyrococcus furiosus. Biochemistry. 
2002;41:7199–7208. 
26. Larrabee JA, Leung CH, Moore R, Thamrong-nawasawat T, Wessler BH. 
Magnetic circular dichroism and cobalt(II) binding equilibrium studies 
of Escherichia coli methionyl aminopeptidase. J Am Chem Soc. 
2004;126:12316–12324. 
27. Wang J, Sheppard GS, Lou P, Kawai M, Park C, Egan DA, Schneider A, 
Bouska J, Lesniewski R, Henkin J. Physiologically relevant metal 
cofactor for methionine aminopeptidase-2 is manganese. Biochemistry. 
2003;42:5035–5042. 
28. Hu XV, Chen X, Han KC, Mildvan AS, Liu JO. Kinetic and mutational 
studies of the number of interacting divalent cations required by 
bacterial and human methionine aminopeptidases. Biochemistry. 
2007;46:12833–12843. 
29. Copik AJ, Nocek B, Swierczek SI, Ruebush S, SeBok J, D’Souza VM, Peters 
J, Bennett B, Holz RC. EPR and X-ray crystallographic characterization 
of the product bound form of the Mn(II)-loaded methionyl 
aminopeptidase from Pyrococcus furiosus. Biochemistry. 
2005;44:121–129. 
30. D’Souza VM, Brown RS, Bennett B, Holz RC. Charaterization of the active 
site and insight into the binding mode of the anti-angiogenesis agent 
fumagillin to the Mn(II)-loaded methionyl aminopeptidase from 
Escherichia coli. J Biol Inorg Chem. 2005;10:41–50. 
31. D’Souza VM, Holz RC. The methionyl aminopeptidase from Escherichia coli 
is an iron(II) containing enzyme. Biochemistry. 1999;38:11079–
11085. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
FEBS Journal, Vol. 275, No. 24 (December 2008): pg. 6248-6259. DOI. This article is © Wiley and permission has been 
granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission for this article to be 
further copied/distributed or hosted elsewhere without the express permission from Wiley. 
27 
 
32. Winzor DJ, Sawyer WH. Quantitative Characterization of Ligand Binding. 
New York, NY: Wiley-Liss; 1995.  
33. Bennett B, Holz RC. EPR studies on the mono- and dicobalt(II)-
substituted forms of the aminopeptidase from Aeromonas proteolytica. 
Insight into the catalytic mechanism of dinuclear hydrolases. J Am 
Chem Soc. 1997;119:1923–1933. 
34. Huntington KM, Bienvenue D, Wei Y, Bennett B, Holz RC, Pei D. Slow-
binding inhibition of the aminopeptidase from Aeromonas proteolytica 
by peptide thiols: synthesis and spectral characterization. 
Biochemistry. 1999;38:15587–15596. 
35. Bienvenue D, Bennett B, Holz RC. Inhibition of the aminopeptidase from 
Aeromonas proteolytica by L-leucinethiol: kinetic and spectroscopic 
characterization of a slow, tight-binding inhibitor–enzyme complex. J 
Inorg Biochem. 2000;78:43–54. 
36. Crawford PA, Yang K-W, Sharma N, Bennett B, Crowder MW. 
Spectroscopic studies on cobalt(II)-substituted metallo-β-lactamase 
ImiS from Aeromonas veronii bν sobria. Biochemistry. 2005;44:5168–
5176. 
37. Vallee BL, Auld DS. Cocatalytic zinc motifs in enzyme catalysis. Proc Natl 
Acad Sci USA. 1993;90:2715–2718.  
38. Vallee BL, Auld DS. New perspective on zinc biochemistry: cocatalytic 
sites in multi-zinc enzymes. Biochemistry. 1993;32:6493–6500. 
39. Lipscomb WN, Sträter N. Recent advances in zinc enzymology. Chem Rev. 
1996;96:2375–2433. 
40. Dismukes GC. Manganese enzymes with binuclear active sites. Chem Rev. 
1996;96:2909–2926. 
41. Sträter N, Lipscomb WN, Klabunde T, Krebs B. Two-metal ion catalysis in 
enzymatic acyl- and phosphoryl-transfer reactions. Angew Chem Int 
Ed Engl. 1996;35:2024–2055. 
42. Wilcox DE. Binuclear metallohydrolases. Chem Rev. 1996;96:2435–2458. 
43. Bazan JF, Weaver LH, Roderick SL, Huber R, Matthews BW. Sequence and 
structure comparison suggest that methionine aminopeptidase, 
prolidase, aminopeptidase-P, and creatinase share a common fold. 
Proc Natl Acad Sci USA. 1994;91:2473–2477.  
44. Oefner C, Douangamath A, D’Arcy AHS, Mareque D, MacSweeney A, 
Padilla J, Pierau S, Schulz H, Thormann M, Wadman S, et al. The 1.15 
Ǻ crystal structure of the Staphylococcus aureus methionyl 
aminopeptidase and complexes with triazole based inhibitors. J Mol 
Biol. 2003;332:13–21. 
45. Maher MJ, Ghosh M, Grunden AM, Menon AL, Adams MW, Freeman HC, 
Guss JM. Structure of the prolidase from Pyrococcus furiosus. 
Biochemistry. 2004;43:2771–2783. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
FEBS Journal, Vol. 275, No. 24 (December 2008): pg. 6248-6259. DOI. This article is © Wiley and permission has been 
granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission for this article to be 
further copied/distributed or hosted elsewhere without the express permission from Wiley. 
28 
 
46. Wilce MCJ, Bond CS, Dixon NE, Freeman HC, Guss JM, Lilley PE, Wilce JA. 
Structure and mechanism of a proline-specific aminopeptidase from 
Escherichia coli. Proc Natl Acad Sci USA. 1998;95:3472–3477. 
47. Chiu C-H, Lee C-Z, Lin K-S, Tam MF, Lin L-Y. Amino acid residues 
involved in the functional integrity of the Escherichia coli methionine 
aminopeptidase. J Bacteriol. 1999;181:4686–4689.  
48. Bertini I, Luchinat C. High-spin cobalt(II) as a probe for the investigation 
of metalloproteins. Adv Inorg Biochem. 1984;6:71–111. 
49. Copik AJ, Swierczek SI, Lowther WT, D’Souza V, Matthews BW, Holz RC. 
Kinetic and spectroscopic characterization of the H178A mutant of the 
methionyl aminopeptidase from Escherichia coli. Biochemistry. 
2003;42:6283–6292. 
50. Bennett B, Holz RC. Spectroscopically distinct cobalt(II) sites in 
heterodimetallic forms of the aminopeptidase from Aeromonas 
proteolytica: characterization of substrate binding. Biochemistry. 
1997;36:9837–9846. 
 
